CAMP
Camp4 Therapeutics Corp
NASDAQ · Healthcare · Biotechnology · US
$4.24
+5.21%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.58
- EPS estimate
- -$0.21
- Revenue actual
- $1.8M
- Revenue estimate
- $1.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -81.9%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.21 | -$0.58 | Miss -174.32% | $1.8M |
| May 7, 2026 | -$0.21 | -$0.32 | Miss -52.38% | $1.3M |
| Mar 5, 2026 | -$0.47 | -$0.87 | Miss -83.93% | $348.0K |
| Nov 6, 2025 | -$0.47 | -$0.55 | Miss -17.02% | $795.0K |
| Aug 14, 2025 | -$0.67 | -$0.62 | Beat 7.46% | $1.5M |
| Mar 27, 2025 | -$0.91 | -$2.83 | Miss -210.99% | $652.0K |
| Oct 11, 2024 | -$1.07 | -$0.69 | Beat 35.59% | — |
| Jul 8, 2024 | -$0.92 | -$1.61 | Miss -75.00% | — |
| Jun 6, 2024 | -$2.04 | -$1.03 | Beat 49.66% | — |
| Jan 9, 2024 | -$2.30 | -$3.91 | Miss -70.00% | $53.6M |
| Oct 5, 2023 | -$0.00 | -$0.01 | Miss -133.10% | $61.7M |
| Jul 10, 2023 | $0.92 | -$0.23 | Miss -125.00% | $70.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026